Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to -$0.0.

  • Cannabis Bioscience International Holdings' EPS (Basic) rose 1705.67% to -$0.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$0.0, marking a year-over-year increase of 8515.74%. This contributed to the annual value of -$0.0 for FY2025, which is 1615.81% up from last year.
  • Per Cannabis Bioscience International Holdings' latest filing, its EPS (Basic) stood at -$0.0 for Q3 2025, which was up 1705.67% from -$0.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year EPS (Basic) high stood at -$0.0 for Q3 2025, and its period low was -$0.0 during Q1 2023.
  • Moreover, its 4-year median value for EPS (Basic) was -$0.0 (2023), whereas its average is -$0.0.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 6052.22% in 2024, then crashed by 8313.89% in 2025.
  • Cannabis Bioscience International Holdings' EPS (Basic) (Quarter) stood at -$0.0 in 2022, then soared by 60.05% to -$0.0 in 2023, then increased by 20.0% to -$0.0 in 2024, then increased by 0.93% to -$0.0 in 2025.
  • Its EPS (Basic) stands at -$0.0 for Q3 2025, versus -$0.0 for Q2 2025 and -$0.0 for Q1 2025.